Identification of a novel function of Twist, a bHLH protein, in the development of acquired taxol resistance in human cancer cells

Oncogene

Volumn 23, Issue 2, 2004, Pages 474-482

  Wang, Xianghong ^a   Ling, Ming Tat ^a   Guan, Xin Yuan ^a   Tsao, Sai Wah ^a   Cheung, Hiu Wing ^a   Lee, Davy Tak ^a   Wong, Yong Chuan ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cancer; Resistance; Taxol; Twist

Indexed keywords

HELIX LOOP HELIX PROTEIN; PACLITAXEL; VINCRISTINE;

ARTICLE; BLADDER CANCER; CANCER CELL; CELL DIFFERENTIATION; CELL TYPE; CONTROLLED STUDY; DNA HYBRIDIZATION; DRUG RESISTANCE; DRUG TARGETING; HUMAN; HUMAN CELL; MICROTUBULE; NASOPHARYNX CARCINOMA; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

DRUG RESISTANCE, NEOPLASM; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HELIX-LOOP-HELIX MOTIFS; HUMANS; INHIBITORY CONCENTRATION 50; MALE; NASOPHARYNGEAL NEOPLASMS; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; PACLITAXEL; PROSTATIC NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TWIST TRANSCRIPTION FACTOR; URINARY BLADDER NEOPLASMS; VINCRISTINE;

EID: 0842286741     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207128     Document Type: Article

References (36)

1. Dumontet C and Sikic BI. (1999). J. Clin. Oncol., 17, 1061-1070.
2. Dupont J, Fernandez AM, Glackin CA, Helman L and LeRoith D. (2001). J. Biol Chem., 276, 26699-26707.
3. El Ghouzzi V, Le Merrer M and Perrin-Schmitt F. (1997). Nat. Genet., 15, 42-46.
4. Funato N, Ohtani K, Ohyama K, Kuroda T and Nakamura M. (2001). Mol. Cell. Biol., 21, 7416-7428.
5. Germann UA.. (1996). Eur. J. Cancer, 32A, 927-944.
6. Giannakakou P, Sackett DL, Kang YK, Zhan Z, Buters JT, Fojo T and Poruchynsky MS. (1997). J. Biol. Chem., 272, 17118-17125.
7. Glaser R, Zhang HY, Yao KT, Zhu HC, Wang FX, Li GY, Wen DS and Li YP. (1989). Proc. Natl. Acad. Sci. USA, 86, 9524-9528.
8. Gu SY, Tang WP, Zeng Y, Zhao EW, Deng WH and Li K. (1983). Chin. J. Cancer, 2, 70-72.
9. Guan XY, Fang Y, Sham JS, Kwong DL, Zhang Y, Liang Q, Li H, Zhou H and Trent JM. (2000). Genes Chromosomes Cancer, 29, 110-116.
10. Haldar S, Chintapalli J and Croce CM. (1996). Cancer Res., 56, 1253-1255.
11. Hjiantoniou E, Iseki S, Uney JB and Phylactou LA. (2003). Biochem. Biophys. Res. Commun., 300, 178-181.
12. Horwitz SB. (1992). Trends Pharmacol. Sci., 13, 134-136.
13. Howard TD, Paznekas WA, Green ED, Chiang LC, Ma N, Ortiz-de-Luna RI, Garcia-Delgado C, Gonzalez-Ramos M, Kline AD and Jabs EW. (1997). Nat. Genet., 15, 36-41.
14. Huang Y, Johnson KR, Morris JS and Fan W. (2000). Cancer Res., 60, 4426-4432.
15. Huang Y, Sheikh MS, Fornace A-JJ and Holbrook NJ. (1999). Oncogene, 18, 3431-3439.
16. Jordan MA, Toso RJ, Thrower D and Wilson L. (1993). Proc. Natl. Acad. Sci. USA, 90, 9552-9556.
17. Kavallaris M, Kuo DY, Burkhart CA, Regl DL, Morris MD, Haber M and Horwitz SB. (1997). J. Clin. Invest., 100, 1282-1293.
18. Lee MS, Lowe GN, Strong DD, Wergedal JE and Glackin CA. (1999). J. Cell Biochem., 75, 566-577.
19. Lin CT, Wong CI, Chan WY, Tzung KW, Ho JK, Hsu MM and Chuang SM. (1990). Lab. Invest., 62, 713-724.
20. Ling MT, Chan KW and Choo CK. (2001). J. Endocrinol., 170, 287-296.
21. Ling MT, Wang X, Ouyang XS, Lee TK, Fan TY, Xu K, Tsao SW and Wong YC. (2002). Oncogene, 21, 8498-8505.
22. Maestro R, Dei-Tos AP, Hamamori Y, Krasnokutsky S, Sartorelli V, Kedes L, Doglioni C, Beach DH and Harmon GJ. (1999). Genes Dev., 13, 2207-2217.
23. McDaid HM and Horwitz SB. (2001). Mol. Pharmacol., 60, 290-301.
24. Moos PJ and Fitzpatrick FA. (1998). Proc. Natl. Acad. Sci. USA, 95, 3896-3901.
25. Olson EN and Klein WH. (1994). Genes Dev., 8, 1-8.
26. Pajer P, Pecenka V, Karafiat V, Kralova J, Horejsi Z and Dvorak M. (2003). Oncogene, 22, 665-673.
27. Ranganathan S, Benetatos CA, Colarusso PJ, Dexter DW and Hudes GR. (1998). Br. J. Cancer, 77, 562-566.
28. Rauh-Adelmann C, Lau KM, Sabeti N, Long JP, Mok SC and Ho SM. (2000). Mol. Carcinogen., 28, 236-246.
29. Rosivatz E, Becker I, Specht K, Fricke E, Luber B, Busch R, Hofler H and Becker KF. (2002). Am. J. Pathol., 161, 1881-1891.
30. Rowinsky EK. (1997). Annu. Rev. Med., 48, 353-374.
31. Sosic D, Richardson JA, Yu K, Ornitz DM and Olson EN. (2003). Cell, 112, 169-180.
32. Thisse B, Stoetzel C, Gorostiza-Thisse C and Perrin-Schmitt F. (1988). EMBO J., 7, 2175-2183.
33. Urakami S, Igawa M, Kikuno N, Yoshino T, Kishi H, Shigeno K and Shiina H. (2002). J. Urol., 168, 2444-2450.
34. Wang X, Jin DY, Ng RW, Feng H, Wong YC, Cheung AL and Tsao SW. (2002). Cancer Res., 62, 1662-1668.
35. Wang X, Jin DY, Wong HL, Feng H, Wong YC and Tsao SW. (2003). Oncogene, 22, 109-116.
36. Yousfi M, Lasmoles F, El Ghouzzi V and Marie PJ. (2002). Hum. Mol. Genet., 11, 359-369.